Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE003234 |
ID: | TCMBANKHE003234 |
植物拉丁名: |
|
功能与主治: | To remove heat and induce diuresis, to relieve edema./Treatment of urinary infection with oliguria, edema and thirst. |
药用植物名: | 冬葵果 |
治疗类型: | 拔毒化腐生肌药 |
TCM_ID_id: | 4788 |
SymMap_id: | 111 |
TCMSP_id: | 923 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000383 | Euphol | CHEMBL465181; (3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; ST24047202; AIDS-064689; ZINC4097719; FT-0698509; AIDS064689; CHEBI:4940; AKOS016010616; Euphol (6CI); AC1L9BGD; (3S,5R,10S,13S,14S)-17-((R)-1,5-Dimethyl-hex-4-enyl)-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; SCHEMBL541497; BG01135940; (20R)-(+)-triucalla-8,24-diene-3beta-ol; AK120346; euphol; (3S,5R,10S,13S,14S,17S)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3beta,13alpha,14beta,17alpha)-Lanosta-8,24-dien-3-ol; Lanosta-8,24-dien-3-ol, (3.beta.,13.alpha.,14.beta.,17.alpha.)-; Euphadienol; (+)-Euphol; (s)-euphol; (+)-alpha-Euphol; AJ-48007; alpha-Euphol; Eupha-8,24-dienol; C08624; 514-47-6; LMPR0106090002; KB-277032; 13alpha,14beta,17betaH-Lanosta-8,24-dien-3beta-ol (8CI); 7162AB | C30H50O | 426.72 | CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
| TCMBANKIN001375 | N-(2-hydroxyethyl)octanamide | SDA 01-022-00; C8-C18 And C18 unsaturated alkylcarboxylic acid amide monoethanol; EINECS 273-927-3; Caprylic acid monoethanol amide; 69227-24-3; N-(2-hydroxyethyl)caprylamide; Octanamide, N-(2-hydroxyethyl)-; Amides, C8-18 and C18-unsatd, N-(hydroxyethyl) | C10H21NO2 | 187.28 g/mol | CCCCCCCC(=O)NCCO |
| TCMBANKIN003530 | 2,6-dimethyl-3,5-dichloro-4-dodecylthiomethyl | ||||
| TCMBANKIN003856 | 1-methyl-6,7-dioxabicyclo[3.2.1]octane | 128.19 | |||
| TCMBANKIN004342 | Z-1,9-Hexadecadiene | (9Z)-hexadeca-1,9-diene | C16H30 | 222.41 g/mol | CCCCCCC=CCCCCCCC=C |
| TCMBANKIN005061 | (Z)-2-octen-2-ol | 128.24 | |||
| TCMBANKIN005762 | 3-o-(2' e,4' e-decadienoyl)-20-o-acetylingenol | C32H44O7 | 540.7 g/mol | CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)COC(=O)C)O)O)C | |
| TCMBANKIN006150 | Euponin | euponin; DTXSID70415122; 70469-59-9; CHEBI:4942; C09449 | C20H24O6 | 360.4 | CC=C(C)C(=O)OC1CC(=C2CC3C(C2C4C1C(=C)C(=O)O4)(O3)C)CO |
| TCMBANKIN006643 | 14,17-Octadecadienoic acid, methyl ester | (14E)-octadeca-14,17-dienoic acid methyl ester; Methyl (14E)-14,17-octadecadienoate; methyl (14E)-octadeca-14,17-dienoate | C19H34O2 | 294.47 | COC(=O)CCCCCCCCCCCCC=CCC=C |
| TCMBANKIN007284 | 3,5-Octadien-2-one, (E,E)- | 3,5-Octadien-2-one; 3,5-Octadien-2-one, #2; (3E,5E)-octa-3,5-dien-2-one; 3,5-Octadien-2-one #1; 38284-27-4; (3E,5E)-3,5-Octadien-2-one | C8H12O | 124.18 | CCC=CC=CC(=O)C |
| TCMBANKIN007671 | Z,Z-2,5-Pentadecadien-1-ol | (2Z,5Z)-pentadeca-2,5-dien-1-ol; (2Z,5Z)-2,5-Pentadecadien-1-ol | C15H28O | 224.38 g/mol | CCCCCCCCCC=CCC=CCO |
| TCMBANKIN007785 | 5- oat sterols | ||||
| TCMBANKIN007907 | 1,1'-bis(2,6-dihydroxy-3-acetyl-4-methoxy-phenyl)methane | C19H20O8 | CC(=O)C1=C(C(=C(C=C1OC)O)CC2=C(C=C(C(=C2O)C(=O)C)OC)O)O | ||
| TCMBANKIN008084 | Daturic acid | 67701-03-5; daturicacid; n-Heptadecylic acid; EINECS 266-928-5; 51610_FLUKA; 67255-22-5; 68424-37-3; NSC3743; (C16-C18)Alkylcarboxylic acid; WLN: QV16; NSC 3743; SDA 19-005-00; 8043-36-5; CH3-[CH2]15-COOH; EINECS 264-123-3; 506-12-7; LMFA01010017; AI3-36481; EINECS 208-027-1; Lead(2+) heptadecanoate; 37231-04-2; Margaric acid; 45237-52-3; n-Heptadecanoic acid; 7722-21-6; 63399-94-0; Heptadecylic acid; n-Heptadecoic acid; 39390-60-8; heptadecoic acid; 8000-11-1; (C16-C18) Alkylcarboxylic acid; daturic acid; C14-C22 Fatty acid residue; Heptadecanoic acid; Margarinsaeure; 8034-57-9; CHEBI:32365; Fatty acids, C14-22; 28829-31-4; 8034-58-0; 1338-46-1; 52051-63-5; EINECS 270-298-7; 8034-56-8; 4-02-00-01193 (Beilstein Handbook Reference); Fatty acids, C16-18; BRN 1781004; 176435-16-8; 45237-51-2; H3500_SIGMA; Margarinic acid | C17H34O2Pb | 478 g/mol | CCCCCCCCCCCCCCCCC(=O)O.[Pb] |
| TCMBANKIN010366 | 3-o-(2' e,4'z-decadienoyl)-5-o-acetylingenol | C32H44O7 | CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)OC(=O)C)O)C | ||
| TCMBANKIN010872 | 1,1-dichloro-2-hexyl-cyclopropane | C9H16Cl2 | 195.13 g/mol | CCCCCCC1CC1(Cl)Cl | |
| TCMBANKIN012446 | Karacolidine | karacolidine | C22H35NO5 | 393.5 g/mol | CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4(C5C6O)O)OC)O)O)C |
| TCMBANKIN014362 | amoxyethylene | Ether, pentyl vinyl; 1-ethenoxypentane; 5363-63-3; 1-(ETHENYLOXY)PENTANE; Pentane, 1-(ethenyloxy)- | C7H14O | 114.19 | CCCCCOC=C |
| TCMBANKIN016308 | euphadienol | C30H50O | 426.7 g/mol | CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C | |
| TCMBANKIN016391 | N-Nitroso-3-pyrroline | 2,5-Dihydro-1-nitroso-1H-pyrrole; BRN 0106739; 1-nitroso-3-pyrroline; 3-PYRROLINE, N-NITROSO-; 3-Pyrroline, 1-nitroso-; Nitroso-3-pyrrolin [German]; 10552-94-0; 1H-Pyrrole, 2,5-dihydro-1-nitroso-; 5-20-04-00277 (Beilstein Handbook Reference); 1-nitroso-2,5-dihydropyrrole | C4H6N2O | 98.1 | C1C=CCN1N=O |
| TCMBANKIN017499 | ()-Dihydrocarveol | 22567-21-1; (1S,2S,5S)-5-Isopropenyl-2-methylcyclohexanol; (1S-(1alpha,2beta,5alpha))-2-Methyl-5-(1-methylvinyl)cyclohexan-1-ol; (1S,2S,5S)-2-methyl-5-prop-1-en-2-yl-cyclohexan-1-ol; (1S,2S,5S)-5-isopropenyl-2-methyl-cyclohexan-1-ol; LMPR01020086; (1S,2S,5S)-5-isopropenyl-2-methyl-1-cyclohexanol; 37277_FLUKA; EINECS 245-085-7; (1S,2S,5S)-2-methyl-5-prop-1-en-2-ylcyclohexan-1-ol; C11413; (1S,2S,4S)-Dihydrocarveol | C10H18O | 154.25 | CC1CCC(CC1O)C(=C)C |
| TCMBANKIN017623 | N-(2-hydroxyethyl)capramide | Amides, C1O-16, N-(hydroxyethyl); Amides, C10-16, N-(hydroxyethyl); N-(2-Hydroxyethyl)decanamide; EINECS 272-736-2; 68910-39-4; Decanamide, N-(2-hydroxyethyl)- | C12H25NO2 | 215.33 g/mol | CCCCCCCCCC(=O)NCCO |
| TCMBANKIN017993 | vitamin c | D01CWN; Cell C; Ronotec 100; P 1110; Suncoat VC 40; D-threo-hex-2-enoic acid gamma-lactone; Citrovit; 2-o-(beta-d-glucopyranosyl)-ascorbic acid_qt; Juvamine; SCHEMBL13468284; Vasc; CHEBI:51384; D-Lyxoascorbic acid; CHEMBL1253320; AK481251; Chewcee; D-xyloascorbic acid; C8DQ5M1Y1E; MLS001066386; AK322241; Ascorbic acid, D-; AC1LD8K5; E 300; Scorbu C; 10504-35-5; Ascorbicacid; l(+)-ascorbic acid; ZINC100006137; L-ascorbate (vitamin C); (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; (+)-Ascorbic acid; UNII-C8DQ5M1Y1E; Ascorbinsaure; Ceklin; VC 97; (2S)-2-[(1R)-1,2-bis(oxidanyl)ethyl]-4,5-bis(oxidanyl)furan-3-one; Vicin; L-ascorbate acid; L-ascorbic acid; L-dehydroascorbic acid; ascorbate; D-threo-hex-2-enono-1,4-lactone; Kangbingfeng; D-Ascorbic acid; Viscorin 100M; ZINC100028197; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-3-furanone; L-Ascorbic acid (8CI,9CI); Proscorbin Redoxon Ribena Ronotec 100; Hex-2-enonic acid gamma-lactone, L-threo; (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one; Ascorbic acid; DL-Ascorbic acid; AKOS000278050; Cebion, gamma-lactone; F91F7DA3-A3D5-4FB4-A6E7-C497C48D192A; GTPL4651; SMR000471843; Xyloascorbic acid, L-; Rontex 100; Rovimix C; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; A828310 | C6H8O6 | 176.12 | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN018715 | histidine | C6H9CuN3O2 | 218.7 g/mol | C1=C(NC=N1)CC(C(=O)O)N.[Cu] | |
| TCMBANKIN019133 | 2-(prop-2-enoytoxy)tetradecane | 284.49 | |||
| TCMBANKIN020041 | euphorbone | ||||
| TCMBANKIN022980 | caprylic acid | Octanoic acid (mixed isomers); AK405365; octoic acid; Sodium octanoate, 96%; Natrium octanoat; D05220; NoO notEa AAENI; W279927_ALDRICH; Sodium caprylate [NF]; KB-80641; ACMC-1BO0W; MCULE-8227046407; AIDS-006110; Caprylsaeure; V0353; Octylic acid; Enantic acid; Caprylic acid sodium salt; Sodium n-octanoate; Sodium octoate; Octanoic acid sodium salt; 68937-74-6; MolPort-006-113-836; EINECS 273-085-7; C-8 acid; 21639_FLUKA; HSDB 5862; AIDS006110; NCGC00090957-02; 0ctanoic acid; BYKRNSHANADUFY-UHFFFAOYSA-M; Acid C-8; caprylic acid, sodium salt; 124-07-2; Acido octanoico [Spanish]; Sodium octanoate, 96% 100g; Octic acid; 124-07-2 (Parent); W279900_ALDRICH; KS-00000YJH; capryloate; Sodium caprylate: Octanoic acid; NCGC00090957-01; Acide octanoique [French]; Sodium caprylate (NF); O0034; UNII-9XTM81VK2B; LS-98001; 18312-04-4; neo-fat 8; OCTANOIC ACID (CAPRYLIC ACID); SODIUM OCTANOATE; 1-heptanecarboxylic acid; NCIOpen2_009358; LS-691; O3907_ALDRICH; 1984/6/1; CHEBI:132100; MFCD00058511; AN-19785; ANW-13619; NCIOpen2_002902; octanoic acid; C2875_SIGMA; I14-14709; TR-009215; Caprylic acid (natural); NSC 5024; CHEBI:28837; Octanoic acid [USAN:INN]; LMFA01010008; n-octylic acid; TRA-0206488; Fatty acids, C6-1O; FEMA No. 2799; BRN 1747180; 4-02-00-00982 (Beilstein Handbook Reference); 9XTM81VK2B; EINECS 204-677-5; CHEMBL557076; Octanoic acid, sodium salt; EINECS 217-850-5; ST51037190; KSC490S9T; caprylic acid ; NSC5024; AI3-50473; SCHEMBL56211; Sodium Salt of Caprylic Acid; Octanoic acid (USAN); Hexacid 898; CH3-[CH2]6-COOH; Sodium caprylate; Sodium caprylate [USAN]; RTR-009215; 27633_RIEDEL; Kaprylsaeure; C06423; Fatty acids, C6-10; caprylicacid; Acidum octanocium [Latin]; HSDB 821; AI3-04162; Kyselina kaprylova [Czech]; n-octanoic acid; FT-0701289; n-caprylic acid; AS-17478; CCRIS 4689; PubChem12870; 21650_FLUKA; n-Octoic acid; W-109735; CTK3J0999; AKOS015901906; OCA; Octansaeure; SC-79959; n-Octanoic Acid Sodium Salt; WLN: QV7; CPD-195; Octanoic acid, sodium salt (1:1); DTXSID3027451; D08999 | C8H16O2 | 144.21 g/mol | CCCCCCCC(=O)O |
| TCMBANKIN025291 | 3-o-(2,3-dimethylbutanoyl)-13-o-dodecanoyl-ingenol | C38H60O8 | |||
| TCMBANKIN026648 | 4,4-dimethyloxolan-2-one | 4,4-dimethyltetrahydrofuran-2-one; 2(3H)-Furanone, dihydro-4,4-dimethyl-; .beta.,.beta.-Dimethyl-.gamma.-butyrolactone; BRN 0107181; 4,4-Dimethylbutyrolactone; Dihydro-4,4-dimethyl-2(3H)-furanone; beta,beta-Dimethylbutylrolacton [German]; 4,4-dimethyl-2-tetrahydrofuranone; 13861-97-7; 5-17-09-00045 (Beilstein Handbook Reference); 4,4-DIMETHYLDIHYDROFURANONE | C6H10O2 | 114.14 | CC1(CC(=O)OC1)C |
| TCMBANKIN027454 | trans-1,2-Cyclopentanediol | ()-trans-1,2-Cyclopentanediol; 459259_ALDRICH; 29722_FLUKA; 1,2-Cyclopentanediol, trans-; 361445_ALDRICH; 29725_FLUKA; NSC15389; 5057-99-8; (1R,2R)-cyclopentane-1,2-diol; (1R,2R)-trans-1,2-Cyclopentanediol | C5H10O2 | 102.13 | C1CC(C(C1)O)O |
| TCMBANKIN027786 | 8-quinolyl octadecanoate | quinolin-8-yl octadecanoate; 86137-76-0; stearic acid 8-quinolyl ester; octadecanoic acid 8-quinolyl ester; NSC179828 | C27H41NO2 | 411.62 | CCCCCCCCCCCCCCCCCC(=O)OC1=CC=CC2=C1N=CC=C2 |
| TCMBANKIN029612 | 7-methyl-Z-tetradecen-1-ol acetate | C17H32O2 | 268.4 g/mol | CCCCCC=CC(C)CCCCCCOC(=O)C | |
| TCMBANKIN030234 | 3-o-(2' e,4' e-decadienoyl)ingenol | C30H42O6 | 498.6 g/mol | CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)O)O)C | |
| TCMBANKIN030265 | 3-o-(2' e,4'z-decadienoyl)ingenol | C30H42O6 | 498.6 g/mol | CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)O)O)C | |
| TCMBANKIN031369 | 3-o-(2' e,4'z-decadienoyl)-20-o-acetylingenol | C32H44O7 | 540.7 g/mol | CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)COC(=O)C)O)O)C | |
| TCMBANKIN032070 | inegnol | ||||
| TCMBANKIN032454 | 3-(prop-2-enoyloxy)dodecane | C15H28O2 | 240.38 g/mol | CCCCCCCCCC(CC)OC(=O)C=C | |
| TCMBANKIN032910 | Ethyl 6-acetoxyhexanoate | 104986-28-9; 6-acetoxyhexanoic acid ethyl ester; Hexanoic acid, 6-(acetyloxy)-, ethyl ester; ethyl 6-acetyloxyhexanoate | C10H18O4 | 202.25 | CCOC(=O)CCCCCOC(=O)C |
| TCMBANKIN033052 | euphorbol | C31H52O | 440.7 g/mol | CC(C)C(=C)CCC(C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C | |
| TCMBANKIN033973 | cyclopropaneoctanoic acid | C18H34O2 | 282.46 | C1CC1CCCCCCCC(=O)O | |
| TCMBANKIN034521 | beta-euphorbol | ||||
| TCMBANKIN037089 | Euphorbetin | 35897-99-5; 5-(6,7-dihydroxy-2-oxochromen-5-yl)-6,7-dihydroxychromen-2-one; AC1NSVDP; 5-(6,7-dihydroxy-2-oxo-5-chromenyl)-6,7-dihydroxy-2-chromenone; euphorbetin; 5-(6,7-dihydroxy-2-oxo-chromen-5-yl)-6,7-dihydroxy-chromen-2-one; 5-(6,7-dihydroxy-2-keto-chromen-5-yl)-6,7-dihydroxy-coumarin; SCHEMBL18172254 | C18H10O8 | 354.27 | C1=CC(=O)OC2=C1C(=C(C(=C2)O)O)C3=C(C(=CC4=C3C=CC(=O)O4)O)O |
| TCMBANKIN037135 | 3-O-benzoyl-13-O-dodecanoateingenol | C39H54O8 | 651 | C1(C([H])([H])[H])=C([H])[C@]2(C(=O)[C@@]([H])([C@]([H])(C3(C([H])([H])[H])C([H])([H])[H])[C@@]3(OC(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C ([H])([H])C([H])([H])[H])=O)C([H])([H])[C@@]2([H])C([H])([H])[H])C([H])=C(C([H])([H])O[H])[C@@]4([H])O[H])[C@@]4(O[H])[C@@]1([H])OC(=O)c5c([H])c([H])c([H])c([H])c5[H] | |
| TCMBANKIN037343 | Kansenone | 440.7 g/mol | |||
| TCMBANKIN037794 | kansuinine A | ZINC95616043; CHEMBL509463; Kansuinine A; Kansuinin A; MolPort-039-338-487; 57701-86-7 | C36H44O15 | 717 | [C@@]1([H])(C([H])([H])[H])C([H])([H])[C@](OC(C([H])([H])[H])=O)([C@]2(O[H])O[C@]([H])(C(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(OC(C([H])([H])[H])=O)[C@]([H])(OC(=O)c(c([H])c([H])c3[H])c([H])c3[H])[ C@]([H])(OC(C([H])([H])[H])=O)C(=C([H])[H])[C@]4([H])OC(C([H])([H])[H])=O)C(=O)C2([H])[H])[C@]4([H])[C@@]1([H])OC(C([H])([H])[H])=O |
| TCMBANKIN038270 | 11-oxo-kansenonol | C30H46O4 | 471 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)C([H])([H])[C@@](C([H])([H])[H])([C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])\C([H])=C([H])\C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C2([H] )[H])[C@]23C([H])([H])[H])=C3C(=O)C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] | |
| TCMBANKIN038432 | 13-Oxyingenol-13-dodecanoate-20-hexanoate | ||||
| TCMBANKIN038583 | 3-O-(2,3-Dimethylbutanoyl)-13-O-dodecanoyl-20-deoxyingenol | 3-o-(2,3-dimethylbutanoyl)-13-o-dodecanoyl-20-deoxyingenol | 628.98 | ||
| TCMBANKIN038804 | 20-o-benzoyl-13-o-dodecanoateingenol | C39H54O8 | 651 | ||
| TCMBANKIN039452 | 20-O-(2,3-Dimethylbutanoyl)-13-O-dodecanoylingenol | 20-O-(2,3-Dimethylbutanoyl)-13-O-dodecanoyl ingenol | 644.98 | ||
| TCMBANKIN039677 | kansenonol | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])\C([H])=C([H])\C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H]) C2([H])[H])[C@]23C([H])([H])[H])=C3C(=O)C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] | |
| TCMBANKIN040700 | kansuiphorin c | C29H34O6 | 478.6 g/mol | CC1CC2C(C2(C)C)C3C=C(C(C4(C1(C3=O)C=C(C4OC(=O)C)C)O)OC(=O)C5=CC=CC=C5)C | |
| TCMBANKIN041202 | kansuiphorin A | CHEMBL450760; 135883-24-8; Kansuiphorin A; kansuiphorin a; Hexadecanoic acid,(6-(2,3-dimethyl-1-oxobutoxy)- 1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-1,1,7,9- tetramethyl-11-oxo-10a-((1-oxododecyl)oxy)-1H-2,8a- methanocyclopenta(a)cyclopropa(e)cyclodecen-4-yl)methyl ester; 13-Hydroxyingenol-3-(2,3-dimethylbutanoate)-13-dodecanoate-20-hexadecanoate; CHEBI:66138; [(1aR,2S,5R,5aS,6S,8aS,9R,10aS)-6-[(2,3-dimethylbutanoyl)oxy]-10a-(dodecanoyloxy)-5,5a-dihydroxy-1,1,7,9-tetramethyl-11-oxo-1a,2,5,5a,6,9,10,10a-octahydro-1H-2,8a-methanocyclopenta[a]cyclopropa[e][10]annulen-4-yl]methyl hexadecanoate | C54H90O9 | 883 | [C@]12(O[H])[C@]([C@]([H])(C([H])([H])[H])C([H])([H])[C@]3(OC(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])=O)[C@@]4([H] )C3(C([H])([H])[H])C([H])([H])[H])(C([H])=C(C([H])([H])[H])[C@]1([H])OC([H])(C([H])([H])[H])C([H])([H])[H])C(=O)[C@]4([H])C([H])=C(C([H])([H])OC(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H]) C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])=O)[C@@]2([H])O[H].C(=C([H])C([H])([H])[H])=O |
| TCMBANKIN041224 | kansuiphorin B | CHEMBL454542; CHEBI:66139; Kansuiphorin B; Hexadecanoic acid,(8-(2,3-dimethyl-1-oxobutoxy)- 1a,2,2a,3a,4,5,8a,9-octahydro-8a,9-dihydroxy-3,3,5,7- tetramethyl-10-oxo-3a-((1-oxododecyl)oxy)-3H-2,5a- methanocyclopenta(4,5)cyclopropa(8,9)cyclodec(1,2-b)oxiren- 9a(8H)-yl)methyl ester; kansuiphorin b; 6,7-Epoxy-13-hydroxyingenol-3-(2,3-dimethylbutanoate)-13-dodecanoate-20-hexadecanoate; [(1aR,2R,2aR,3aS,5R,5aS,8S,8aS,9S,9aS)-8-[(2,3-dimethylbutanoyl)oxy]-3a-(dodecanoyloxy)-8a,9-dihydroxy-3,3,5,7-tetramethyl-10-oxo-2,2a,3,3a,4,5,8a,9-octahydro-1aH-2,5a-methanocyclopenta[4,5]cyclopropa[8,9]cyclodeca[1,2-b]oxiren-9a(8H)-yl]methyl hexadecanoate; 135928-39-1 | C54H90O10 | 899.3 g/mol | CCCCCCCCCCCCCCCC(=O)OCC12C(O1)C3C4C(C4(CC(C5(C3=O)C=C(C(C5(C2O)O)OC(=O)C(C)C(C)C)C)C)OC(=O)CCCCCCCCCCC)(C)C |
| TCMBANKIN041272 | stearic acid | 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 | C18H36O2 | 284 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O |
| TCMBANKIN042479 | kansuinine b | Kansuinine B; SCHEMBL1231379; CHEMBL3813747; 57685-46-8; AC1L9C65; C09122; Kansuinin B; CHEMBL448506; DTXSID80331728; CHEBI:6111; MolPort-044-754-172 | C38H42O14 | 722.73 | CC1C2C(O2)C(C(=O)C(C(C(=C)C(C3C(C(C(C3(C1=O)OC(=O)C)O)(C)O)OC(=O)C)OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)O)(C)C |
| TCMBANKIN042754 | 20-o-(decanoyl)ingenol | C30H46O6 | 502.7 g/mol | CCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C | |
| TCMBANKIN042858 | Luteolin | Prestwick3_000870; TNP00073; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-); 62696_FLUKA; ACon1_000223; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; Digitoflavone; SMR000326896; luteolin-7-olate anion; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; CHEBI:57545; FLAVONE, 3',4',5,7-TETRAHYDROXY-; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; A827664; BPBio1_001011; MEGxp0_000143; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- (9CI); Weld Lake; BSPBio_000919; CHEBI:15864; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; Oprea1_849964; Yama kariyasu; 4-[5,7-bis(oxidanyl)-4-oxidanylidene-chromen-2-yl]-2-oxidanyl-phenolate; ST024703; luteolin ; NCGC00016467-02; EINECS 207-741-0; AIDS001406; NCGC00142375-02; C.I. Natural Yellow 2; S00110; Luteoline; Luteolin; Luteolol; 3′,4′,5,7-Tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Prestwick_122; 5,7,3',4'-Tetrahydroxyflavone; BRN 0292084; CAS-491-70-3; 4-(5,7-dihydroxy-4-oxo-1-benzopyran-2-yl)-2-hydroxyphenolate; ZINC00008613; NCGC00142375-01; Prestwick1_000870; AIDS-001406; C01514; CCRIS 3790; 3',4',5,7-Tetrahydroxyflavone; Flacitran; Cyanidenon 1470; MLS000697655; SPBio_002840; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Lopac0_000660; NCGC00016467-01; C.I. 75590; Prestwick0_000870; 491-70-3; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-oxylato-4H-1-benzopyran-4-one; 5-18-05-00296 (Beilstein Handbook Reference); Prestwick2_000870; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; L9283_SIGMA; 3′,4′,5,7-Tetrahydroxyflavone; SMP2_000042; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone | C15H10O6 | 286.236 | c1(O[H])c([H])c(OC(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C([H])C3=O)c3c(O[H])c1[H] |
| TCMBANKIN043771 | epi-kansenone | C30H48O2 | 441 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H]) C2([H])[H])[C@]23C([H])([H])[H])=C3C(=O)C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] | |
| TCMBANKIN044426 | kansuinin c | C38H42O14 | 722.7 g/mol | CC1C2C(O2)C(C(=O)C(C(C(=C)C(C3C(C(C(C3(C1=O)O)OC(=O)C)(C)O)OC(=O)C)OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)O)(C)C | |
| TCMBANKIN044658 | Kansuinin F | KANSUININ F; CHEMBL508061 | 776.8 g/mol | ||
| TCMBANKIN045065 | Tirucallol | (3S,5R,10S,13S,14S)-17-((S)-1,5-Dimethyl-hex-4-enyl)-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13S,14S)-17-[(1S)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13S,14S)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; AC1LAPT0; Tirucalla-8,24-dien-3 beta-ol | 426.72 | ||
| TCMBANKIN046835 | Kansuinin E | KANSUININ E; CHEMBL506248 | 777.8 g/mol | ||
| TCMBANKIN047002 | 6alpha-methyl-2alpha,6beta-dihydroxymethyl-bicyclo[3.1.1]heptane-2alpha-o-glucoside | 6α-methyl-2α,6β-dihydroxymethylbicyclo[3.1.1]heptane-2α-o-glucoside | C16H28O7 | CC1(C2CCC(C1C2)COC3C(C(C(C(O3)CO)O)O)O)CO | |
| TCMBANKIN047121 | Kansuinin D | CHEMBL500170; KANSUININ D | 793.8 g/mol | ||
| TCMBANKIN047336 | Kansenol | 441 | |||
| TCMBANKIN047454 | 3-o-(2,3-dimethylbutanoyl)-13-o-dodecanoyl-20-acetylingenol | C40H62O9 | |||
| TCMBANKIN048616 | Kansuiphorin D | 478.6 g/mol | |||
| TCMBANKIN048947 | 13-Oxyingenol | 364.4 g/mol | |||
| TCMBANKIN049214 | Kansuinin H | 730.8 g/mol | |||
| TCMBANKIN050224 | kansuinin g | C34H43NO13 | 673.7 g/mol | CC1CC2(C(C1OC(=O)C)C(C(=C)C(C(C(C(C3C(O3)C(C2=O)C)(C)C)OC(=O)C4=CN=CC=C4)O)OC(=O)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN058004 | trigonelline | Prestwick_70; N-Methylnicotinic acid betaine hydrochloride; 1-methyl-3-pyridin-1-iumcarboxylate hydrochloride; MFCD00077250; SCHEMBL468365; A833196; trigonelline ; trigonelline HCl; 1-methylpyridin-1-ium-3-carboxylate hydrochloride; AC1O4WFS; 1-Methylpyridinium-3-carboxylate hydrochloride; T-6500; CHEMBL489961; trigonellin; gynesine; trigonelline | C7H7NO2 | 137.14 g/mol | C[N+]1=CC=CC(=C1)C(=O)[O-] |
| TCMBANKIN058267 | vitamin b | NSC169454; SR-01000722017-4; Nicotinic acid, >=98%; [3H]nicotinic acid; Nicotinamide (JP15/INN); AC1Q73P3; C6H5NO2; 11054-EP2289510A1; NCGC00094734-02; AB00052050; HMS3655K08; Efacin; Nico-400; N1103; 11054-EP2298772A1; TR-032523; C00253; Nicosan 3; SPBio_000011; Nicotinic Acid [Matrix for MALDI-TOF/MS]; SPBio_002881; 5-22-02-00057 (Beilstein Handbook Reference); Niacinamide Astra Brand; Spectrum3_000515; ANW-75276; Bionic; 11054-EP2301923A1; SDCCGMLS-0066610.P001; Nicotinsaure [German]; Nicotinic acid, >=99.5% (HPLC); preventative factor; 28029-53-0 (cobalt(2+) salt); SR-01000722017-3; Acide nicotinique [INN-French]; 11054-EP2295409A1; NICO; InChI=1/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9; D00049; Jenapharm Brand of Niacinamide; Nicotinamide (TN); Niacin [USAN]; bmse000104; 1976-28-9 (aluminum salt); 11054-EP2311816A1; Apelagrin; AN-23622; KBio2_001543; ABT-919; Acido nicotinico; .beta.-Pyridinecarboxylic acid; Niaspan (TN); 11054-EP2270002A1; SR-01000722017-2; KB-33243; Pellagramin; NCGC00016268-02; DSSTox_CID_932; Merck Brand of Niacinamide; nicobid; beta-pyridinecarboxylic acid; BDBM23515; 3PyrCOOH; Nicotinic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=98%; Pellagra preventive factor; niacin; Prestwick0_000881; Nicotinic acid, Ph Eur; BPBio1_000730; Nicacid; UNII-2679MF687A; EBD2198325; NCGC00016268-08; 3-Carboxypyridine; ST097540; Z56755709; Davitamon PP; Nicotinamide (Niacinamide); Nicotinic acid, analytical standard; CPD000059024; 3-Pyridylcarboxylic acid; Pyridine-beta-carboxylic acid; KBioSS_001543; 11054-EP2305674A1; Nicotinic acid, for synthesis, 99%; Nicodon; Oprea1_514398; [5, 6-3H]-niacin; 636-79-3 (hydrochloride); Direktan; Niacin (Nicotinic Acid), Pharmaceutical Secondary Standard; Certified Reference Material; DB-007765; 11054-EP2298742A1; Nyclin; 11054-EP2316827A1; NSC-169454; 7069-06-9 (magnesium salt); 11054-EP2316826A1; Niacor; niacine; MLS000069603; AC-907/25014105; GTPL1594; Spectrum5_001287; RP00705; niacin potassium; BSPBio_002069; STR00112; IDI1_000695; LS-2334; AM81316; NAH; P.P. factor-pellagra preventive factor; AC-22484; Vitaplex N; Nicodan; 3789-96-6 (tartrate); 11054-EP2311829A1; AB1002056; Niacinamide Merck Brand; Spectrum4_000965; Pyridinecarboxylic acid, 3-; CCRIS 1902; 11054-EP2308838A1; SBI-0051456.P003; 11054-EP2280001A1; Nicotinic acid [INN]; PubChem2594; Nicovasen; 54-86-4 (hydrochloride salt); 11054-EP2274983A1; 11054-EP2308854A1; NCGC00016268-04; MCULE-3788394698; Nicagin; nicolar; NIASPAN TITRATION STARTER PACK; AB00052050-13; ST2413625; J-523605; 36321-41-2 (ammonium salt); Acido nicotinico [INN-Spanish]; Akotin; EINECS 200-441-0; SBB004279; 11054-EP2311830A1; Niacin, United States Pharmacopeia (USP) Reference Standard; Acidum nicotinicum; Nikasan; SR-01000722017; AK-46486; Enduracin; CS-1946; Nicotinic acid, certified reference material, TraceCERT(R); Induracin; Nico-Span; antipellagra vitamin; 3-pyridine carboxylic acid; Nicoside; Nicotinic acid, purum, >=99.0% (HPLC); CHEMBL573; Pyridylcarboxylic Acid; Tinic; 11054-EP2295424A1; EPA Pesticide Chemical Code 056701; Nicotine acid; Ncotnc acd; 11054-EP2305651A1; pellagra; Nicorol; 5-pyridinecarboxylic acid; NCGC00094734-01; 11054-EP2298776A1; 3-Picolinic acid; Niacin; Pellagra preventive factor; Pyridine-3-carboxylic acid; Vitamin B3; KBioGR_001309; 11054-EP2308848A1; KSC236Q9T; Nipellen; Niacin (USP); 3-pyridinecarboxylic acid; Vitamin B3 (Niacin); KBio2_006679; NCI60_001041; HMS2236A05; AB00052050_14; Nicotinic acid, matrix substance for MALDI-MS, >=99.5% (HPLC); HMS2097B04; Spectrum2_000006; 99148-57-9 (tosylate); SCHEMBL1433; BSPBio_000662; MolPort-000-142-273; KBio3_001569; 10361-13-4 (iron(2+) salt); Tox21_110337_1; F2191-0082; Acide nicotinique; Nicotinic acid, European Pharmacopoeia (EP) Reference Standard; 11054-EP2269990A1; 11054-EP2308858A1; M-5918; 11054-EP2275401A1; Nicotinic acid, plant cell culture tested; Nicotinic acid, SAJ special grade, >=99.5%; Niacinamide (TN); HMS3714B04; STK301803; Pelonin; Niconazid; Prestwick2_000881; Nicovasan; 11054-EP2270014A1; Niacinamide Pharmagenix Brand; Pharmakon1600-01500430; Pyridine-carboxylique-3 [French]; SK-Niacin; Prestwick1_000881; Nikazan; EC 200-441-0; PP Factor; AKOS000118980; HY-B0143; Tox21_110337; HMS3371E07; WLN: T6NJ CVQ; Nicotene; Nicotinic acid [INN:BAN]; CAS-59-67-6; 11054-EP2316458A1; Kyselina nikotinova [Czech]; P.P. factor; Pyridine-3-carboxylic acid; Niacin (nicotinic acid); Tox21_201420; L001199; NCGC00016268-09; nicocap; I02-0699; nicotinic acid; Niconat; ZINC1795; Niacin [USP]; Diacin; 11054-EP2272825A2; Kyselina nikotinova; FC1287; Nicotinic acid-d3(major); CHEBI:15940; 823-77-8 (calcium salt); Niacor (TN); DSSTox_RID_75875; NCGC00256537-01; Nicotamin; GTPL1588; 2679MF687A; ACMC-1AS6M; [3H]-Nicotinic acid; SPECTRUM1500430; Acidum nicotinicum [INN-Latin]; HMS1570B04; 11054-EP2301937A1; KBio1_000695; BP-21419; Niacinamide Jenapharm Brand; AJ-08093; Nicotinic acid, NIST(R) SRM(R) 148; niacin magnesium; Nicyl; S115; Tega-Span; 11054-EP2269610A2; KBio2_004111; AC1L1AD5; NCGC00016268-01; Niacinamide, Nicotinic acid amide, Nicotinamide; Opera_ID_1346; Nicotinic acid, 99% 250g; 3-Pyridyl carboxylic acid; Nicocidin; nicotinate; s1744; SR 4390; DTXSID1020932; Nicotinsaure; 16518-17-5 (potassium salt); Nicotinic acid, Vetec(TM) reagent grade, >=98%; 11054-EP2308839A1; Linic; BIDD:GT0644; NC00524; wampocap; NCGC00016268-03; Nicotinic acid, for inorganic trace analysis, >=99.999% (metals basis); AB00052050_15; Nicosyl; CCG-38340; D06NVJ; 11054-EP2301935A1; 11054-EP2308874A1; Nikotinsaeure; SC-05611; Pyridine-3-carbonic acid; Nicodelmine; 53890-72-5 (lithium salt); 11054-EP2311808A1; SMR000059024; Daskil; NSC 169454; MFCD00006391; PS-4255; HMS502C17; 11054-EP2272848A1; FT-0082580; Pyridine-.beta.-carboxylic acid; DivK1c_000695; 11054-EP2295406A1; Niacin-Vitamin B3; N0082; BRN 0109591; 3-Carboxylpyridine; 11054-EP2316828A1; Niac; NCGC00258971-01; 3-Picolinic acid; 11054-EP2292610A1; NINDS_000695; 11054-EP2292228A1; FT-0600004; Astra Brand of Niacinamide; Nicotinic Acid 1.0 mg/ml in Methanol; 11054-EP2272834A1; HMS3259K21; Niacin (TN); Nicotinic acid (JP17/INN); NSC-757241; Prestwick3_000881; Niaspan; Slo-niacin; SAM002554917; HMS2091H22; Pharmagenix Brand of Niacinamide; 59-67-6; NCGC00016268-05; Tox21_302904; Pellagrin; Caswell No. 598; 11054-EP2277848A1; 3DDB011E-F3A6-45B6-A2D2-77B2A6E8936E; 11054-EP2301929A1; 11054-EP2311817A1; Naotin; m-Pyridinecarboxylic acid; vitamin B3; HSDB 3134; Peviton; nicamin; Nicotinic acid (Vitamin B3) solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Nicangin; Spectrum_001063; Pyridine-carboxylique-3; KB-259513; 11054-EP2298779A1; Nicocrisina; DB00627; 11054-EP2316825A1; AI3-18994; PVNIIMVLHYAWGP-UHFFFAOYSA-N; 11054-EP2316457A1; I14-92791; anti-Pellagra vitamin; 28029-54-1 (manganese(2+) salt); NSC757241; 123574-58-3; Nicotil; HMS1920P17; Nicotinipca; 3-Pyridinecarboxylicacid; 11054-EP2314588A1; Niconacid; NIO; Nicotinic acid, meets USP testing specifications; DSSTox_GSID_20932; Nicotinamide-carbonyl-14C | C5H4NCOOH | 123.11 g/mol | C1=CC(=CN=C1)C(=O)O |
| TCMBANKIN058920 | 3-acetyl-2,6-dihydroxy-4-methoxybenzaldehyde | methyl(2,4-dihydroxy-3-formyl-6-methoxy)phenylketone; methyl(2,4-dihydroxy-3-formyl-6-methoxy)-phenylketone | C10H10O5 | 210.18 | CC(=O)C1=C(C=C(C(=C1O)C=O)O)OC |
| TCMBANKIN059532 | (1R)-1, 7, 7-trimethyl-bicyclo[2.2.1]heptan-2-one | C10H16O | 152.23 g/mol | CC1(C2CCC1(C(=O)C2)C)C | |
| TCMBANKIN060264 | rutin | C27H30O16 | 610.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O | |
| TCMBANKIN060410 | 13-oxyingenol | C20H28O6 | 364.4 g/mol | CC1CC2(C(C2(C)C)C3C=C(C(C4(C1(C3=O)C=C(C4O)C)O)O)CO)O | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060865 | 3-o-(2e,4z-decadienoyl)-20-deoxyingenol | C30H42O5 | CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)C)O)O)C | ||
| TCMBANKIN060866 | 20-o-(2'e,4’z-decadienoyl)ingenol | C30H42O6 | CCCCCC=CC=CC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C | ||
| TCMBANKIN060868 | trans-2,4-decadienal | C10H16O | 152.23 g/mol | CCCCCC=CC=CC=O | |
| TCMBANKIN060879 | Linolic acid | C18H32O2 | 280.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060906 | trans-2-nonenal | C9H16O | 140.22 g/mol | CCCCCCC=CC=O | |
| TCMBANKIN060917 | (E)-2-nonen-1-ol | C9H18O | 142.24 g/mol | CCCCCCC=CCO | |
| TCMBANKIN060944 | nonanoic acid | C9H18O2 | 158.24 g/mol | CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060969 | Erucic acid | C22H42O2 | 338.57 | CCCCCCCCC=CCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061045 | PENTADECYLIC ACID | C15H30O2 | 242.4 g/mol | CCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061118 | behenic acid | C22H44O2 | 340.6 g/mol | CCCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061207 | Di-n-butyl phthalate | C16H22O4 | 278.34 g/mol | CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC | |
| TCMBANKIN061577 | FER | Ferulate; Coniferic acid; Cinnamic acid, 4-hydroxy-3-methoxy- (8CI); KBio1_001587; Spectrum5_000554; SDCCGMLS-0066667.P001; NCGC00094889-02; AIDS017864; 3-methoxy-4-hydroxy-trans-cinnamic acid; CCRIS 3256; trans-4-Hydroxy-3-methoxycinnamic acid; 97274-61-8; (E)-4'-Hydroxy-3'-methoxycinnamic acid; Cinnamic acid, 4-hydroxy-3-methoxy-, (E)-; SBB000326; Cinnamic acid, 4-hydroxy-3-methoxy-; NCGC00094889-03; InChI=1/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13; 3-(4-Hydroxy-3-methoxyphenyl)acrylic acid; SMR000112202; 4-Hydroxy-3-methoxycinnamic acid; 3-Methoxy-4-hydroxy-trans-cinnamate; Ferulic acid, trans-; 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid; Spectrum2_001394; KBio3_002388; 4-Hydroxy-3-methoxy cinnammic acid; 1135-24-6; CHEBI:17620; transferulic acid NCGC00094889-01; EINECS 208-679-7; Spectrum3_001434; NCI60_002312; NSC51986; Ferulic acid dehydrogenation homopolymer; EINECS 214-490-0; CCRIS 7575; KBio2_006872; KBio2_004304; FERULOATE; 537-98-4; Spectrum_001256; caffeic acid 3-methyl ether; 128708_ALDRICH; Cinnamic acid, 4-hydroxy-3-methoxy-, trans-; NSC 674320; 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (E)- (9CI); MLS001066385; 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-; BSPBio_003168; NSC2821; SPBio_001408; 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, (E)-; 46278_FLUKA; (E)-Ferulic acid; (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid; 3-methoxy-4-hydroxycinnamic acid; FERULIC-ACID; SpecPlus_000547; KBioSS_001736; AIDS-017864; Spectrum4_001897; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid; 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid homopolymer; SPECTRUM1501017; FERULIC ACID (TRANS); 3-(4-hydroxy-3-methoxy-phenyl)acrylic acid; (E)-3-(4-hydroxy-3-methoxy-phenyl)acrylic acid; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid; DivK1c_006643; C01494; KBioGR_002459; 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid; NSC 51986; 3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid; ferulic acid; KBio2_001736; CINNAMIC ACID,4-HYDROXY,3-METHOXY FERULIC ACID; NSC 2821; W518301_ALDRICH; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid; Trans-ferulic acid; 3-methoxy-4-hydroxycinnamic acid | C10H10O4 | 194.18 g/mol | COC1=C(C=CC(=C1)C=CC(=O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab